-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Undergoes Intellectual Property Management System Certification Audit
Category:
发布时间：2020-05-26
【概要描述】
From May 22 to 23, an audit team from Zhongzhi (Beijing) Certification Co., Ltd. conducted a two-day audit of the operation of the intellectual property management system at Shijiazhuang Sihua Pharmaceutical Co., Ltd.
From May 22 to 23, an audit team from Zhongzhi (Beijing) Certification Co., Ltd. conducted a two-day audit of the operation of the intellectual property management system at Shijiazhuang Sihua Pharmaceutical Co., Ltd.
During the inspection, the review experts conducted an in-depth and meticulous examination of the operation of the company’s intellectual property management system, covering product research and development, production and operations, and related management practices, through discussions with representatives of the management team.
At the final meeting, the expert panel stated that the company’s intellectual property management system continues to comply with and remain effective in meeting the relevant requirements, and agreed to recommend the retention of its certification status.
In recent years, Shijiazhuang Sihua Pharmaceutical has continuously refined its intellectual property management system through innovative and creative development practices, conducted strategic research and implementation on intellectual property, intensified IP training, and established a scientifically sound IP management process. In May 2018, the company obtained certification for its intellectual property management system; in 2019, it was recognized as a “National Intellectual Property Advantage Enterprise.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091